Zuluita, Shairah M.

HRN: 22-35-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/22/2022
12/28/2022
IV
350mg
Q6Hrs
PCAP-C; Tc PTB
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: